BBS-Bioactive Bone Substitutes Oyj (HLSE:BONEHN0122) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BONEHN0122 Stock Overview

A biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.

About the company

BONEHN0122 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Risk Analysis

Earnings have declined by 8% per year over past 5 years

Makes less than USD$1m in revenue (€0)

Does not have a meaningful market cap (€9M)

Shares are highly illiquid

+ 2 more risks

BBS-Bioactive Bone Substitutes Oyj Competitors

IntegraGen

ENXTPA:ALINT

€3.4m

NexImmune

OTCPK:NEXI

US$348.7k

Innovation Pharmaceuticals

OTCPK:IPIX

US$105.9k

Galmed Pharmaceuticals

NasdaqCM:GLMD

US$6.0m

Price History & Performance

Summary of all time highs, changes and price drops for BBS-Bioactive Bone Substitutes Oyj
Historical stock prices
Current Share Price	€1.28
52 Week High	€1.42
52 Week Low	€1.28
Beta	-0.52
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-2.03%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BONEHN0122	FI Biotechs	FI Market
7D	-1.9%	-1.8%	0.9%
1Y	n/a	-1.0%	-3.5%

Return vs Industry: Insufficient data to determine how BONEHN0122 performed against the Finnish Biotechs industry.

Return vs Market: Insufficient data to determine how BONEHN0122 performed against the Finnish Market.

Price Volatility

Is BONEHN0122's price volatile compared to industry and market?
BONEHN0122 volatility
BONEHN0122 Average Weekly Movement	n/a
Biotechs Industry Average Movement	7.7%
Market Average Movement	4.3%
10% most volatile stocks in FI Market	7.2%
10% least volatile stocks in FI Market	2.6%

Stable Share Price: BONEHN0122 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BONEHN0122's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	21	Ilkka Kangasniemi	www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.

BBS-Bioactive Bone Substitutes Oyj Fundamentals Summary

How do BBS-Bioactive Bone Substitutes Oyj's earnings and revenue compare to its market cap?
BONEHN0122 fundamental statistics
Market cap	€8.69m
Earnings (TTM)	-€2.77m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-3.1x

P/E Ratio

Is BONEHN0122 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BONEHN0122 income statement (TTM)
Revenue	€0
Cost of Revenue	€56.95k
Gross Profit	-€56.95k
Other Expenses	€2.71m
Earnings	-€2.77m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 25, 2022

Earnings per share (EPS)	-0.41
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	170.8%

How did BONEHN0122 perform over the long term?

See historical performance and comparison